Pear Therapeutics, based in Boston, is a pioneer in Prescription Digital Therapeutics (PDTs), aiming to enhance patient outcomes, offer intelligent engagement and tracking tools for clinicians, and provide cost-effective solutions for payers.
The company's focus on developing PDTs underscores its commitment to revolutionizing healthcare by leveraging technology to improve treatment effectiveness and accessibility.
Generated from their website's infomation